Results 151 to 160 of about 2,931,165 (316)

Disaster, Participatory Science, and Infrastructure

Citizen Science: Theory and Practice, 2022
Shannon Dosemagen, Aya H. Kimura, Scott Frickel, Alison Parker   +3 more
doaj   +1 more source

Wikidata for botanists: benefits of collaborating and sharing Linked Open Data. [PDF]

Ann Bot
von Mering S, Leachman S, Santos J, Meudt HM.   +3 more
europepmc   +1 more source

Cataclysmic Variables: An Empirical Angular Momentum Loss Prescription from Open Cluster Data [PDF]

, 2003
N. Andronov, Marc H. Pinsonneault, Alison Sills   +2 more
openalex   +1 more source

Comprehensive omics‐based classification system in adult patients with B‐cell acute lymphoblastic leukemia

Molecular Oncology, EarlyView.
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song, Ting Liu, Qishan Hao, Qiuyun Fang, Xiaoyuan Gong, Yan Li, Zheng Tian, Hui Wei, Min Wang, Jianxiang Wang, Tao Cheng, Yingchang Mi   +11 more
wiley   +1 more source

The rise of open data practices among bioscientists at the University of Edinburgh. [PDF]

PLoS One
Deeb H, Creasey S, de Ugarte DL, Strevens G, Usman T, Wong HY, Kutzer MAM, Wilson E, Zieliński T, Millar AJ.   +9 more
europepmc   +1 more source

Absolute proper motions of open clusters - I. Observational data [PDF]

, 2000
Holger Baumgardt, C. Dettbarn, R. Wielen
openalex  

Finding Frequent Itemsets based on Open Data Mining in Data Streams [PDF]

, 2003
Joong Hyuk Chang, Won Suk Lee
openalex   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source

A lack of open data standards for large infrastructure projects hampers social-ecological research in the Brazilian Amazon. [PDF]

PeerJ
Hyde JL, Swanson C, Bohlman SA, Athayde S, Bruna EM, Valle DR.   +5 more
europepmc   +1 more source

Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment

Molecular Oncology, EarlyView.
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop, Edgar Cardenas De La Hoz, Hanne Verswyvel, Joey De Backer, Ho Wa Lau, Angela Privat‐Maldonado, Wim Vanden Berghe, Steve Vanlanduit, Evelien Smits, Annemie Bogaerts, Abraham Lin   +10 more
wiley   +1 more source